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in vivo analysis presented herein is a new method for the in 
vivo visualization of the very early changes in the hepatic 
parenchyma caused by obstructive cholestasis. 
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 Introduction 
 Obstructive cholestasis is caused by a structural or me-
chanical obstruction of bile flow in the extrahepatic bile 
duct. The common reasons include choledocholithiasis 
and malignant processes such as cholangiocarcinoma and 
pancreatic cancer. It is a serious illness that may lead to 
jaundice and even death unless the obstructive lesion is 
removed or the bile duct is bypassed  [1] . The pathological 
process of developing liver cirrhosis is best characterized 
in animals studied by common bile duct ligation (CBDL). 
CBDL impairs bile formation and excretion into the intes-
tine. This impairment results in elevated blood levels of 
several bile solutes such as cholesterol, bile acids and bili-
rubin that are normally excreted into bile  [2, 3] .
 The pathophysiology of obstructive cholestasis repre-
sents an almost inconceivably complex network of inter-
acting cells, fibrogenic mediators, and extracellular ma-
trix (ECM) molecules  [4] . Dramatic improvements in cell 
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 Abstract 
 Obstructive cholestasis is caused by mechanical constriction 
or occlusion leading to reduced bile flow. Serious complica-
tions such as jaundice and even death may follow. Little is 
known about the initial phase of cholestasis and its conse-
quences for the hepatic microarchitecture. This in vivo study 
aimed to characterize the nature and kinetics of developing 
obstructive cholestasis and focused on areas with biliary sta-
sis and infarction by visualizing the autofluorescence of bile 
acids using intravital microscopy of the liver over a period of 
30 h after bile duct ligation in rats. The innovation resided in 
performing fluorescence microscopy without applying fluo-
rescent dyes. In animals subjected to obstructive cholestasis, 
the most significant changes observed in vivo were the con-
comitant appearance of (1) areas with bile accumulation in-
creasing in size (6 h: 0.163  8 0.043, 18 h: 0.180  8 0.086, 30 h: 
0.483  8 0.176 mm 2 /field) and (2) areas with biliary infarction 
(6 h: 0.011  8 0.006, 18 h: 0.010  8 0.004, 30 h: 0.010  8 0.050 
mm 2 /field) as well as (3) a relation between the formation of 
hepatic lesions and enzyme activity in serum. The sequential 
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and molecular biological techniques now permit detailed 
analysis of the composition, structure, immunology and 
histological localization of the individual components of 
the ECM. Dissection of the cellular and molecular patho-
biology of ECM deposition includes the identification of 
the cellular sources of specific ECM components as well 
as the definition of humoral factors and regulatory loops 
underlying both the amplification and degradation path-
ways of ECM molecules during fibrogenesis  [5] . 
 Besides the molecular aspects of fibrogenesis, which 
have been studied in depth, there is a lack of information 
about the initial steps of hepatic microarchitectural and 
microvascular changes during cholestasis in vivo. Using 
intravital microscopy in a rat model of developing cho-
lestasis, the present study shows the nature, extent and 
relevance of biliary stasis and necrosis in the process of 
hepatic organ remodeling in vivo.
 Methods 
 Animal Model 
 Experiments were performed in accordance with the German 
legislation on the protection of animals and the  Guide for the Care 
and Use of Laboratory Animals (NIH publication No. 86-23, re-
vised in 1985). A total of 20 male Sprague-Dawley rats (Charles 
River, Fa. Wiga, Sulzfeld, Germany, body weight about 280 g) were 
anesthetized with an intraperitoneal injection of pentobarbital so-
dium (50 mg/kg body weight), and laparotomy was performed for 
CBDL (n = 17). Control rats underwent an identical surgical pro-
cedure without CBDL, however (n = 3). All animals were allowed 
to recover from anesthesia and surgery under a red warming lamp 
and were housed in single cages in an environmentally controlled 
room with a 12-hour light-dark cycle with free access to water and 
standard pellet food. The animals were studied at 6 h (n = 4), 18 h 
(n = 3) and 30 h (n = 3) after CBDL. Seven animals (3 from the 
6-hour group, 2 from the 18-hour group, and 2 from the 30-hour 
group) died before the treatment period was completed.
 In vivo Studies 
 For intravital microscopy, the animals were anesthetized with 
an intraperitoneal injection of pentobarbital sodium (50 mg/kg 
body weight) at the respective time points after CBDL and placed 
in the supine position on a heating pad for maintenance of body 
temperature at 37   °   C. After tracheotomy, the right carotid artery 
was exposed and cannulated for heart rate and blood pressure 
monitoring (PE-50; ID 0.58 mm; Portex, Hythe, UK). After trans-
verse and longitudinal laparotomy, the liver was prepared for in-
travital fluorescence microscopy by placing the left lobe on a plas-
ticine disk held by an adjustable stage that was attached to the 
heating pad  [6] . Thereby, the lower surface of the liver was hori-
zontal to the microscope, which guaranteed an adequate homo-
geneous focus level for the microscopic procedure of the liver sur-
face. In addition, adjustment of the plasticine disk allowed us to 
avoid mechanical obstruction of feeding and draining macroves-
sels and to minimize respiratory movements of the lobe. The ex-
posed area of the left liver lobe was immediately covered with a 
glass slide to prevent tissue drying and the influence of ambient 
oxygen. At the end of the experiments, i.e. after intravital micro-
scopic analysis of the hepatic microstructure, the animals were 
killed by exsanguination. Venous blood samples were taken for 
spectro-photometric determination of serum activities of aspar-
tate aminotransferase (AST), alanine aminotransferase (ALT), 
total bilirubin (BILI-T) and direct/conjugated bilirubin (BILI-D). 
Indirect/unconjugated bilirubin (BILI-ID) was determined by 
subtracting BILI-D from BILI-T.
 Intravital Fluorescence Microscopy 
 In vivo microscopy was performed using a modified fluores-
cence microscope (Axio-Tech Vario; Zeiss, Jena, Germany) and 
the epi-illumination technique with a 100-watt mercury lamp. 
Microscopic images were registered by a charge-coupled device 
video camera (FK 6990-IQ; Pieper, Berlin Germany) and record-
ed on video tape for subsequent off-line evaluation. Using a  ! 10 
objective (10 ! /0.30, Zeiss), or a water immersion objective (20 ! /
0.5, Zeiss), magnifications of  ! 300 and  ! 700 were achieved on 
the video screen (PVM-1442 QM, diagonal: 330 mm, Sony). By 
means of different filter sets, images of autofluorescence of the 
hepatic surface (10–15 observation areas per animal) were taken. 
For detection of autofluorescent areas with bile accumulation or 
biliary necrosis, blue fluorescence epi-illumination (excitation/
emission wavelengths: 450–490 nm/ 1 520 nm) was used. Ultra-
violet epi-illumination (330–390 nm/ 1 430 nm) allowed for ob-
servation of multiple patchy fluorescent activities derived from 
vitamin A in Ito cells  [7] and completely eliminated vitamin A 
autofluorescence within about 20 s of exposure due to its rapid 
photobleaching property  [7] .
 Quantitative Analysis 
 Quantitative analysis was performed off-line by a computer-as-
sisted image analysis system (CapImage; Zeintl, Heidelberg, Ger-
many). The extent of biliary accumulation and/or biliary infarction 
was (1) planimetrically quantified as areas per observation field 
(given in square millimeters per visual field) and (2) counted as 
number of areas with (a) biliary accumulation, (b) biliary infarc-
tion or (c) combined lesions (each given as number per visual field) 
using the blue epi-illuminated microfluorographic images. The 
number of positive vitamin A sites was calculated as number per 
square millimeter in (1) unaffected periportal fields and (2) affect-
ed periportal fields with lesions such as biliary stasis or infarction 
using ultraviolet epi-illuminated microfluorographic images.
 Histology 
 Liver tissue samples were fixed in 4% phosphate-buffered for-
malin for 2–3 days and embedded in paraffin. From the paraffin-
embedded tissue blocks, 5-  m sections were cut and stained with 
hematoxylin and eosin (HE) for routine histology and examined 
by light microscopy and blue fluorescence epi-illumination (exci-
tation/emission wavelengths: 450–490 nm/ 1 515 nm).
 Statistics 
 Data are presented as means  8 SEMs. After performing a nor-
mality test, statistical differences at different time points after 
CBDL versus values of control rats without CBDL were deter-
mined by one-way analysis of variance followed by a Holm-Sidak 
comparison test. Data were considered significant when p  ! 0.05.
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 Results 
 Gross Findings 
 The average body weight of the control animals and 
the animals with cholestasis at 6, 18 and 30 h did not dif-
fer (284  8 7, 312  8 22, 335  8 45 and 268  8 20 g, respec-
tively). At laparotomy of cholestatic animals, neither 
changes of liver surfaces nor signs of portal hypertension, 
namely splenomegaly, ascites, and increased diameter of 
the portal vein and its intestinal afferents were observed. 
Calculation of liver to body weight ratios indicated in-
creasing liver hypertrophy with values of 3.7  8 0.2, 3.5 
 8 0.4 and 4.1  8 0.3% after 6, 18 and 30 h CBDL com-
pared with the corresponding liver to body weight ratio 
of control animals (2.5  8 1.4%). 
 Intravital Microscopic Morphology 
 Intravital observation of biliary autofluorescence 
(450–490 nm/ 1 520 nm) revealed remarkable differences 
regarding the extent and quality of initially occurring le-
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 Fig. 1. Intravital fluorescence microscopic 
images of periportal fields in an untreated 
control liver ( a ) and liver at 6 h ( b ), 18 h ( c ), 
and 30 h ( d ) after CBDL. Whereas the 
morphology of the liver parenchyma is 
normal in the control animal ( a ), initial 
changes of hepatic parenchyma with pro-
nounced accumulation of bile originating 
from the periportal field are apparent al-
ready after 6 h of cholestasis ( b ), increasing 
in size with time ( c ) and finally occupying 
a whole triangular portal field ( d ). Blue-
light epi-illumination. Bars represent 100 
  m.  e Quantitative analysis revealed a 
progressively increasing bile accumula-
tion after CBDL. Means  8 SEM,  * p  ! 0.05 
vs. 0 h. 
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sions between control and CBDL animals as well as be-
tween cholestatic animals at different time points after 
CBDL ( fig. 1 ). Cumulated bile was observed very early in 
periportal fields of animals 6 h after CBDL (0.163  8 0.043 
mm 2 /visual field). The extent of bile accumulation in-
creased by more than 10 and 160%, respectively (0.180  8 
0.086 mm 2 /visual field and 0.483  8 0.176 mm 2 /visual 
field) at 18 and 30 h after CBDL. As expected, hepatic de-
fects such as dark areas of infarction or bile-associated 
autofluorescence in areas of biliary stasis could not be ob-
served in control animals ( fig. 1 ). Infarction areas present-
ing with poor autofluorescence in blue-light epi-illumina-
tion were observed as solitary, periportal lesions in ani-
mals at 6 h after CBDL ( fig. 2 b). Although the size of areas 
with cholestatic bile was clearly increasing, the number of 
lesions with accumulated bile in relation to the number of 
infarction sites was remarkably decreasing over time by 
more than 50% ( fig. 2 e). This might be explained by the 
concomitant observation that 6, 18 and 30 h after CBDL, 
combined lesions showing both biliary stasis and infarc-
tion were increasingly occurring in 33  8 13, 40  8 12 and 
57  8 18% of visual fields, respectively ( fig. 2 f). The whole 
hepatic parenchyma revealed obviously increasing bile-
associated autofluorescence in blue-light epi-illumination 
with increasing duration of cholestasis.
 No remarkable differences were observed between the 
CBDL and control animals with respect to acinar distri-
bution of vitamin A-associated autofluorescence. The 
mean number of cells showing vitamin A-associated au-
tofluorescence was unchanged in the unaffected peripor-
tal fields of animals at 6 h (1,175  8 172/mm 2 ) and 18 h 
after CBDL (1,347  8 162/mm 2 ) compared to control an-
imals (1,380  8 169/mm 2 ). However, in periportal fields 
with lesions such as biliary stasis or infarction, the mean 
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 Fig. 2. Intravital fluorescence microscopic images of liver paren-
chyma before ( a ), as well as 6 h ( b ), 18 h ( c ), and 30 h ( d ) after 
CBDL. The liver of a control animal reveals no biliary lesions ( a ), 
while after CBDL, areas with bile accumulation (arrows), biliary 
stasis (arrowheads), and combined lesions (asterisk) could be ob-
served ( b ,  c ). At 30 h after CBDL, the whole liver parenchyma is 
brightened up ( d ) in comparison to the control ( a ). Blue epi-illu-
mination. Bars represent 100   m. Quantitative analysis shows a 
decrease in the relation of area count with bile accumulation to 
area count with biliary infarction from 6 to 18 and 30 h after 
CBDL, respectively ( e ). In parallel, there is an increasing fraction 
of visual fields presenting areas with both bile accumulation and 
infarction ( f ). Means  8 SEM. 
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a b
 Fig. 3. HE histology ( a ) and blue fluorescence epi-illumination ( b ) of the identical liver section at 6 h after CBDL. 
Deposits of intracytoplasmic bile pigments could be observed (arrowheads). Bars represent 20   m. 
a b c
d e f
0 h
30 h 18 h 30 h
6 h 18 h
 Fig. 4. HE-stained liver sections of an untreated control animal ( a ) and animals at 6 h ( b ), 18 h ( c ,  e ) and 30 h ( d , 
 f ) after CBDL. Whereas regular liver histology was found in control animals ( a ), severe confluent necrotic fields 
(asterisks) are apparent after CBDL ( b – d ). At 18 h ( e ) and 30 h ( f ) after CBDL, proliferating bile ductules (arrows) 
surrounded by neutrophils (arrowheads) may be observed. Bars represent 100   m ( a–d ) or 50   m ( e ,  f ). 
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number of cells with vitamin A-associated autofluores-
cence was markedly lower in animals at 6 h (772  8 118/
mm 2 ) and 18 h after CBDL (617  8 24/mm 2 ) compared to 
control animals. Because of enhanced biliary autofluo-
rescence in the whole hepatic parenchyma at 30 h after 
CBDL, clear identification of unaffected periportal fields 
was not possible any more.
 Liver Histology 
 In HE-stained liver sections, deposits of intracytoplas-
mic bile pigments could already be observed at 6 h after 
CBDL ( fig. 3 a). By blue fluorescence epi-illumination of 
the identical field, bile accumulation became even more 
visible ( fig. 3 b). Whereas the microarchitecture of liver 
histology was found regularly in control animals ( fig. 4 a), 
we already observed severe lesions such as confluent ne-
crotic fields in CBDL animals ( fig. 4 b–d). Furthermore, 
the HE-stained liver sections showed proliferating bile 
ductules surrounded by neutrophils at 18 and 30 h after 
CBDL ( fig. 4 e, f).
 Plasma Analysis 
 Concomitantly, liver enzyme activities in serum in-
creased more than 8-fold (AST: 1,059  8 188 U/l) and 
9-fold (ALT: 413  8 96 U/l) already at 6 h after CBDL com-
pared with values of control animals (AST: 131  8 7 U/l; 
ALT: 43  8 5 U/l). Serum AST activity did not further in-
crease at later time points with enduring cholestasis (18 h 
CBDL, AST: 1,085  8 250 U/l; ALT: 516  8 181 U/l; 30 h 
CBDL, AST: 1,047  8 194 U/l; ALT: 540  8 72 U/l;  fig. 5 ). 
Compared to control animals (1.73  8 0.16   mol/l), se-
rum BILI-T activity was found to steadily increase by 
more than 35-fold within 30 h after CBDL (6 h: 27.2  8 
2.1, 18 h: 47.4  8 5.8, 30 h: 61.6  8 9.8   mol/l). After 
CBDL, serum BILI-D activity revealed a constant in-
crease (6 h: 15.8  8 2.3, 18 h: 11.4  8 1.6, 30 h: 37.4  8 9.2 
  mol/l), whilst the activity of unconjugated bilirubin was 
found to be almost 6-fold increased at 6 h after CBDL 
(11.4  8 1.6   mol/l), reached a steady state between 6 and 
18 h (10.0  8 3.9   mol/l) and raised again between 18 and 
30 h by about 68% (16.7  8 3.2   mol/l;  fig. 6 ).
 Discussion 
 Cholestasis is a clinically significant entity because of 
its association with significant morbidity and sometimes 
mortality  [8] . Treatments for cholestasis remain largely 
nonspecific and often ineffective  [9] . Cholestasis is attrib-
uted to stagnation of toxic hydrophobic bile acids and is 
accompanied with cytoplasmic changes in periportal he-
patocytes  [10] . Elevated serum and tissue levels of bile salts 
and other toxic compounds during cholestasis may cause 
mitochondrial damage, apoptosis or necrosis in suscep-
tible cell types  [3, 11] . Bilirubin, the principal breakdown 
product of hemoglobin and other hemepro teins, is nor-
mally excreted with the bile. Impaired bile excretion in 
liver disease or in instances of obstruction in the biliary 
duct system causes a rise in the plasma bilirubin concen-
tration that eventually leads to clinical jaundice. In the 
present study, hepatic retention of bilirubin pigments dur-
ing CBDL-induced obstructive cholestasis was investigat-
ed for the first time in vivo. For this purpose, we used the 
autofluorescence of bilirubin most probably emitted by a 
tetrapyrrole prosthetic group  [12] . The innovation resides 
in performing fluorescence microscopy without applying 
fluorescent dyes. The faint autofluorescence of the liver 
parenchyma enabled clear visualization of the hepatic mi-
crovascular structure and demonstration of the kinetics 
of morphological changes caused by accumulation of bil-
irubin in hepatocytes, bile canaliculi and bile ducts from 
which hepatic parenchymal damage takes its origin and 
to correlate these changes with hepatobiliary function at 
a very early stage of obstructive cholestasis. 
 As expected, we observed increasing biliary autofluo-
rescence during progression of cholestasis, corresponding 
to enhanced bilirubin pigment storage in the cytoplasm 
of hepatocytes as an initially consequence of cholestasis. 
The increase in cytoplasmatic autofluorescence may be 
explained by an immediate downregulation of canalicu-
lar excretion transporters as a consequence of mechanical 
impedance of bile flow  [13] . In parallel, a decreased uptake 
of bile solutes from sinusoids by reducing inward trans-
porters keeps more solutes in the sinusoids and hence in 
the circulation  [13] . As a marker for reduced hepatic up-
take, we found an increase in serum BILI-ID activity 
along with significantly increased bile accumu lation.
 Bile lakes were reported to occur in obstructive jaun-
dice due to bile acid accumulation, and their appearance 
in the periportal area is characteristic of severe bile duct 
obstruction  [14] . The toxic action of bile is assumed to 
cause bile infarction in extrahepatic biliary obstruction 
 [15] . In our intravital fluorescence microscopic approach, 
bile infarcts appear as nonfluorescent areas in direct vi-
cinity to bile lakes. Our in vivo data showed the incidence 
of bile infarcts already 6 h after CBDL. Whereas at 6 h af-
ter CBDL these areas mostly appear as solid infarcts, 18 
and 30 h after onset of obstructive cholestasis, we found a 
raised count of areas with combined lesions (bile lakes and 
bile infarcts) as typical parenchymal damage following 
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thrombosis and thus rupture of bile canaliculi ( fig.  2 ). 
Concomitantly, we histologically observed proliferating 
bile ductules with an adjacent inflammatory reaction rep-
resenting severe lesions already occurring at 18 and 30 h 
after CBDL. Combined defects were often located in por-
tal and para-periportal areas. It might be speculated that 
within the first 6 h after CBDL, infarcts mainly occur in 
areas affected by lytic cell necrosis after cytoplasmic cho-
lestasis whereas subsequently, infarction preponderantly 
follows canalicular thrombosis. Our results are further 
confirmed by increasing activity of hepatic transaminases 
in serum which suggest the occurrence of cytoplasmic and 
mitochondrial damage within the first 6 h of cholestasis.
 It has been reported that Ito cells (hepatic stellate cells) 
are the principal effectors of liver fibrogenesis  [16] . As 
disease progresses, these vitamin A-rich cells become ac-
tivated, proliferate and produce ECM  [17, 18] . We did not 
observe any difference between CBDL animals and con-
trols with respect to acinar distribution of vitamin A-as-
sociated autofluorescence or the mean number of hepatic 
Ito cells in inconspicuous periportal fields. Nevertheless, 
our present data show lower vitamin A-associated auto-
fluorescence in affected periportal fields with lesions 
such as biliary stasis or infarction in rats 6 and 18 h after 
CBDL. These findings suggest that imaging of bile acids 
by intravital fluorescence microscopy may be used for 
early, reliable detection and classification of hepatic 
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pathophysiological changes after the onset of obstructive 
cholestasis.
 Over a period of weeks or months, untreated cholesta-
sis causes lytic cell necrosis. As long as the cause of biliary 
obstruction persists, biliary fibrosis and cirrhosis may oc-
cur. Our present data show changes in the hepatic paren-
chyma occurring immediately after CBDL and allow the 
identification of their etiopathogenesis. Our data further-
more suggest an emerging switch to more severe stages of 
obstructive cholestasis already 30 h after CBDL and pro-
vide an imaging method that supports and complements 
previous biochemical and molecular studies  [13, 19, 20] .
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 Fig. 5. Extent of biliary infarction in livers of animals at 6, 18 and 
30 h after CBDL compared to control animals and its relation to 
the serum AST and ALT activity. Whereas no infarction sites were 
found in normal livers, infarction areas of nearly the same extent 
could be observed at all time points after CBDL. Consistently, se-
rum AST and ALT activity increased more than 8-fold (AST) and 
9-fold (ALT) at 6 h after CBDL and remained elevated at later time 
points. Means  8 SEM,  * p  ! 0.05 vs. 0 h. 
 Fig. 6. Extent of bile accumulation in livers of animals at 6, 18 and 
30 h after CBDL compared to control animals and its relation to 
serum BILI-D and BILI-ID activity. Whereas no areas of accumu-
lated bile were found in normal livers, these areas were continu-
ously increasing after CBDL. In parallel, serum BILI-D activity 
steeply increased after CBDL. Serum BILI-ID activity displayed 
an increase at 6 h after CBDL without a further rise at later time 
points. Means  8 SEM,  * p  ! 0.05 vs. 0 h. 
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